Scythian Biosciences

SCYB-CA:TSX

Miscellaneous Commercial Services

Market Cap

—

MICRO cap

Share Price ←

(—)

YTD Return ←

—

since start of 2021

P/E Ratio

—

Corporate Values

Carbon Footprint
Pollution Prevention
Water Conservation
Data & Privacy Protection
Consumer Health, Wellness & Safety
Employee Ownership, Satisfaction, Benefits & Pay
Workplace Health and Safety
Integrity of Corporate Governance
Ethical Practices
Usage of Conflict Materials
Forced Labor
Diversity of Corporate Leadership

About

Miscellaneous Commercial Services Founded null

Scythian Biosciences Corp. engages in development of drug therapies. It specializes in the development of a proprietary cannabinoid-based combination drug therapy for the treatment of concussions and traumatic brain injury. It also intends to develop other potential cannabinoid and non-cannabinoid based pharmaceutical products, including one that is in development for treatment of gastro-inflammatory disease. The company is headquartered in Toronto, Canada.

website

Headquarters

Suite 200

366 Bay Street

Toronto, ON M5H 4B2

1.212.729.9208

Executives

Name	Title	Gender

Mindful Investing Summary

Carbon Footprint

— N/A
Pollution Prevention

— N/A
Water Conservation

— N/A
Data & Privacy Protection

— N/A
Consumer Health, Wellness & Safety

— N/A
Employee Ownership, Satisfaction, Benefits & Pay

— N/A
Workplace Health and Safety

— N/A
Integrity of Corporate Governance

— N/A
Ethical Practices

— N/A
Usage of Conflict Materials

— N/A
Forced Labor

— N/A
Diversity of Corporate Leadership

— N/A

Scythian Biosciences - Competitors and Related Companies

How Scythian Biosciences stacks up to its peers in the Miscellaneous Commercial Services industry or with competing business segments.